PM

Neurotransmission, Pharmacology, and Neural Learning: Pain, Mood, and Plasticity

Pain signals, endorphins, and pain modulation

  • When you get stabbed or injured, you would want the sharp pain signal to travel to your brain so you can respond. Pain signals are sent from the site of injury toward the brain.
  • After the initial pain signal is sent, endorphins are released and act to block those pain signals, reducing the experience of pain.
  • There are substances that mimic or resemble GABA (the brain’s major inhibitory neurotransmitter) as well as substances similar to endorphins. Opiates (e.g., morphine, heroin) are examples of endorphin mimics; they bind to endorphin receptors and reduce pain while often producing a pleasant feeling.
  • Runner’s high: prolonged running can trigger excessive endorphin release due to sustained tissue damage and pain. Endorphins reduce pain and create a pleasant sensation similar to the effect some people experience with opioids.
    • Caution: heroin is addictive, costly, and often adulterated with dangerous substances. Moderation in running is better for health than excessive long-distance running, which can damage the body.
  • Summary: endorphins provide natural pain relief and mild euphoria; this system is part of why strenuous exercise can feel rewarding, but misuse or external opiates carry significant risks.

Serotonin vs. dopamine: mood, motivation, and reward

  • Both serotonin and dopamine are linked to pleasant experiences, but they play different roles and are often conflated.
  • Serotonin
    • Neurotransmitter primarily implicated in mood and emotional regulation; often summarized as contributing to happiness or positive mood.
    • Deficiencies in serotonin can be associated with mood disorders; medications that influence serotonin can elevate mood by increasing serotonin's availability or action.
    • Serotonin release can occur due to non-purposive factors (e.g., a sunny day) and can contribute to a general sense of well-being or contentment.
    • By itself, serotonin’s release can also promote a sense of “stop” or reduced motivation once things feel adequate, contributing to amotivation in some contexts.
  • Dopamine
    • Associated with the pleasant feelings that come from goal-directed activities and achievement.
    • When you pursue a goal (e.g., outlining a paper, gathering resources, working toward a deadline), the brain rewards progress with dopamine release.
    • Dopamine makes you want to continue pursuing a goal; it is strongly linked to motivation and the pursuit of further actions.
  • Key distinction
    • Serotonin is often linked to stopping, satiety, and mood stability (amotivational release in some contexts).
    • Dopamine is linked to motivation and the drive to pursue goals and rewards.
    • Both contribute to positive affect, but their signaling roles differ: serotonin influences mood and inhibition, dopamine drives action toward goals.

How neurons communicate: the basics of synaptic transmission

  • Neurons communicate via electrochemical signals that follow an all-or-none rule: when an action potential arrives at the axon terminal, it triggers neurotransmitter release; the signal is either full-strength or not fired at all.
  • The strength of a signal is largely governed by the firing rate: a strong signal corresponds to rapid firing; a weak signal to a slower firing rate.
  • The basic architecture:
    • Presynaptic neuron has terminal branches that release neurotransmitters into the synapse.
    • Neurotransmitters float in the synaptic cleft and bind to receptor sites on the postsynaptic neuron's dendrites.
    • Binding can be excitatory or inhibitory, facilitating or dampening the next neuron's likelihood of firing.
  • The lock-and-key metaphor is often used: neurotransmitters are keys; receptor sites are locks. Certain keys open doorways to the next neuron, while other bindings may not trigger the intended response.

Autoreceptors, reuptake, and enzymes: stopping the signal

  • Autoreceptors (on the presynaptic neuron) play a crucial role in signaling when there are enough neurotransmitters in the synapse.
    • When neurotransmitters bind to autoreceptors, they tell the sending neuron to slow down or stop releasing more neurotransmitters.
    • This helps prevent excessive signaling and potential hyperactivity across the neural network.
  • Release dynamics and the risk of too much signaling
    • Neurons tend to release an excess of neurotransmitters to increase the likelihood that some will bind to receptor sites and elicit a signal.
    • If too many neurotransmitters bind, signaling could become excessive; autoreceptors help regulate this.
  • Reuptake (reabsorption) of neurotransmitters
    • After release and signaling, the neuron reabsorbs some of the neurotransmitters (reuptake) to limit ongoing signaling and recycle materials for future use.
    • Reuptake is not perfect; some neurotransmitters remain in the synapse for a time until they are degraded.
  • Degradation by enzymes
    • Extracellular enzymes in the synaptic fluid break down leftover neurotransmitters into constituent components, which are later reabsorbed and repurposed.
  • Why this matters
    • The balance between release, autoreceptor signaling, reuptake, and enzymatic degradation controls the strength and duration of synaptic signaling.
    • Proper functioning of these steps is essential for normal cognition, mood regulation, and behavior; dysfunction can contribute to mental health disorders.

Psychopharmacology: how drugs modulate neurotransmission (agonists vs antagonists)

  • Two broad classes of psychopharmaceuticals:
    • Agonists: enhance neurotransmitter activity; facilitate signaling.
    • Antagonists: impede neurotransmitter activity; blunt signaling.
  • Analogy: offensive line vs defensive line
    • Agonists are like the offensive line aiding the quarterback and receivers to move the ball forward.
    • Antagonists are like the defensive line blocking the play and impeding progress.
  • Mechanisms by which drugs affect neurotransmission
    • Production: drugs can increase or decrease neurotransmitter synthesis in the neuron.
    • Release: drugs can promote or inhibit the release of neurotransmitters into the synapse.
    • Mimicry (receptor binding): some drugs act as mimics, binding to receptor sites and triggering downstream effects (agonists); others bind without triggering an effect or block binding (antagonists).
  • Examples
    • Opiates (e.g., morphine, heroin): agonists for endorphin receptors; produce analgesia and euphoria by increasing endorphin-like activity.
    • Beta blockers: antagonists at receptors for epinephrine and norepinephrine; reduce sympathetic arousal (used to manage anxiety and blood pressure).
    • Reuptake inhibitors (e.g., SSRIs for serotonin): inhibit the reuptake of neurotransmitters, increasing their time in the synapse and their chance to bind receptors.
  • Practical considerations and caveats
    • Simply flooding the system with an agonist can have broad and potentially harmful effects; targeted approaches aim to modulate specific pathways with fewer side effects.
    • Medication strategies often involve gradual buildup to achieve therapeutic effects while minimizing side effects.
    • Reuptake inhibitors offer a way to modulate neurotransmission by extending the presence of neurotransmitters in the synapse, particularly for deficient systems (e.g., serotonin in depression).
    • Contraindications and drug interactions are important: combining agonists and antagonists for the same neurotransmitter or concurrent medications can be dangerous; always discuss medications with a physician to avoid adverse interactions.
  • Takeaway
    • Understanding agonists, antagonists, reuptake, and enzymatic degradation helps explain how medications can be used to treat mental health conditions and why side effects occur.

Neural networks and learning: three theories of how the brain learns

  • Three theories of learning at the neural level: 1) Neurogenesis
    • Idea: learning new things leads to the growth of new neurons (birth/growth of neural tissue).
    • Evidence considerations:
      • Early life shows rapid neural density increases (e.g., density is much higher at age 6 than at birth), suggesting a relationship between learning and neural growth.
      • However, long after early childhood, neural density tends to decline, and growth slows dramatically in teens and after, suggesting limited ongoing neurogenesis to support lifelong learning.
      • The speed of new neuron growth is typically not rapid enough to account for learning in minutes or days; you don’t observe immediate neuron birth as you learn new material.
    • Conclusion: neurogenesis alone is not a comprehensive explanation for how we learn; it likely contributes to development and certain contexts but cannot explain lifelong learning alone.
      2) Synaptogenesis
    • Idea: learning strengthens and increases the efficiency of connections (synapses) between neurons that are used.
    • Mechanism: when a neuron fires again, it tends to fire with the same potency, but the pathways between neurons become more efficient and easier to activate; this makes it more likely that the next neuron fires in a given pathway — this is synaptogenesis.
    • Consequences: pathways that are frequently used become more robust; those that aren’t used weaken or fail to reinforce.
      3) Synaptic pruning
    • Idea: unused or maladaptive connections are weakened or eliminated over time.
    • Mechanism: if a neuron’s activity does not support correct signals or learns incorrect responses, those connections are pruned (atrophy) so they become less likely to be activated in the future.
    • Consequences: neural networks become more efficient by removing redundant or erroneous pathways; this supports more accurate decision-making and learning.
  • How these theories work together
    • Early development: rapid growth provides a rich neural hardware base; learning relies on forming many connections (synaptogenesis).
    • Throughout life: learning refines networks via strengthened useful connections and pruning of unused ones (synaptic pruning).
  • Analogies and imagery
    • Forest analogy for neural pathways: initially many possible paths through a forest; frequently used paths become well-worn and easier to traverse; unused paths become overgrown and harder to use.
  • Evidence and interpretation
    • The data support synaptogenesis and pruning as core mechanisms of learning and brain refinement, with neurogenesis playing a more limited or context-specific role.

Neuroplasticity and developmental timing: limits and implications

  • Neuroplasticity refers to the brain’s ability to reorganize itself by forming new neural connections.
  • There are important limits to plasticity:
    • Younger brains tend to be more plastic and malleable due to higher neural density and the presence of many potential pathways.
    • As you age, pathways become more refined and some alternative routes disappear, making major rewiring more difficult.
    • While neuroplasticity persists into adulthood, the capacity to rewire is reduced compared to early life; recovery and learning may require different strategies and longer time scales.
  • Sensitive periods
    • There are windows in development when the brain is especially receptive to certain types of learning and reorganization.
    • The instructor notes that there will be a further discussion on sensitive periods and neuroplasticity later in the course (Friday).
  • Practical implications
    • Early experiences and learning can shape neural networks more profoundly and quickly than similar efforts later in life.
    • Therapeutic approaches for adults may need to leverage existing networks and targeted training to maximize plasticity, rather than expecting wholesale rewiring.
    • Understanding plasticity helps explain why rehabilitation after injury or effective educational strategies can have differential outcomes across the lifespan.

Connections, implications, and takeaways

  • The brain’s communication system relies on precise timing and regulation of signaling, including the roles of autoreceptors, reuptake, and enzymatic degradation; disruption in these processes can contribute to mental health issues.
  • Medications can modulate these processes by acting as agonists or antagonists, or by altering reuptake dynamics; such interventions require careful management to balance therapeutic benefits with potential side effects.
  • Learning is not simply about growing new neurons; it is more about refining and strengthening existing neural networks through synaptogenesis and pruning, processes that are heavily influenced by experience and age.
  • The interplay between mood, motivation, and reward (serotonin and dopamine) underpins how people experience well-being and how they pursue goals, with distinct roles that can be leveraged or dysregulated in mental health contexts.
  • Real-world relevance includes mental health treatment planning, understanding the risks of illicit substances, exercise and well-being, educational strategies across the lifespan, and the design of interventions that harness neuroplasticity without unwanted side effects.

Formulas and core concepts (highlights)

  • Action potential and signaling strength (conceptual):
    • An action potential is an all-or-none event with fixed potency; signal strength is primarily encoded by the firing rate: ext{signal strength} \propto r where r is the firing rate.
  • Neurotransmitter clearance (conceptual):
    • Reuptake, autoreceptors, and enzymatic degradation regulate synaptic neurotransmitter levels. A simple schematic can be summarized as: release → receptor binding → autoreceptor feedback → reuptake → enzymatic breakdown.
  • Receptor dynamics (conceptual):
    • Agonists mimic neurotransmitters and activate receptors; antagonists block receptors and inhibit signaling; partial agonists produce intermediate effects.
  • Endorphin system and opioids (conceptual):
    • Endorphins bind to endogenous receptors to reduce pain and produce pleasant sensations; opiates act as agonist mimics to enhance this effect.
  • Dopamine vs serotonin roles (conceptual):
    • Dopamine drives goal-directed action and reward anticipation; serotonin relates to mood regulation and signaling to pause or halt certain behaviors or states.